Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

DOI

10.1111/bjh.16971

Type

Journal article

Journal

Br J Haematol

Publication Date

10/2020

Volume

191

Pages

171 - 193

Keywords

BCR-ABL, CML, imatinib, tyrosine kinases, Adolescent, Adult, Allografts, Aniline Compounds, Antineoplastic Combined Chemotherapy Protocols, Bone Marrow Transplantation, Child, Child, Preschool, Dasatinib, Drug Resistance, Neoplasm, Female, Hematology, Humans, Imatinib Mesylate, Imidazoles, Interferon-alpha, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Male, Nitriles, Pyridazines, Pyrimidines, Quinolines, Societies, Medical, United Kingdom